CollPlant Biotechnologies Ltd Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations
CollPlant Biotechnologies Ltd (CLGN) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations of $22.28 million as of 2023-06-30, per its 6-K filed 2023-08-24.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations · last filed 2023-08-24
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $22.28M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $29.65M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $36.29M.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $13.15M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations |
|---|---|
| 2023-06-30 | $22.28M 6-K · filed 2023-08-24 |
| 2022-12-31 | $29.65M 20-F · filed 2023-03-29 |
| 2022-06-30 | $36.29M 6-K · filed 2023-08-24 |
| 2021-12-31 | $13.15M 20-F · filed 2023-03-29 |
| 2020-12-31 | $3.33M 20-F · filed 2023-03-29 |